NCT00201994View on ClinicalTrials.gov

"SALT-2 Trial Study of Ascending Levels of Tolvaptan in Hyponatremia"

PHASE3CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

July 31, 2005

Conditions
HyponatremiaWater IntoxicationInappropriate ADH SyndromeWater-electrolyte Imbalance
Interventions
DRUG

Tolvaptan

Trial Locations (1)

D-01307

Universitatskilinikum Carl, Gustav Carus

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY